Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>News>This Article

Autoclave Sealing Parts Withstand 4 Months Aggressive In-situ Testing

Published: Friday, October 18, 2013
Last Updated: Friday, October 18, 2013
Bookmark and Share
DuPont™ Kalrez® 6230 perfluoroelastomer seals from Dichtomatik.

Autoclaves are widely used to sterilize equipment with high pressure saturated steam at temperatures of 121°C or more. These conditions can be maintained for 15 to 20 minutes, depending upon the size of the system load and the contents.

Pressurized, high temperature steam is, however, one of the most aggressive operating environments, but this is necessary to achieve the high level of operating sterility and purity within the autoclave.

In between system loads, autoclaves are also subject to continuous cleaning cycles at high pressure/temperature steam conditions.

Typical autoclave applications include pharmaceuticals, microbiology, medicine, veterinary and mycology sciences, together with dentistry and general laboratories.

A growing application covers the pre-disposal treatment and sterilization of waste material, including pathogenic hospital waste to neutralize potentially infectious agents.

Because of such challenging applications, it is of paramount importance that autoclave components withstand the operating conditions.

Autoclaves can contain in excess of 200 seals that need to maintain their performance in hot pressurized saturated steam, as well as also being FDA and USP Class VI compliant.

The DuPont™ Kalrez® 6230 perfluoroelastomer (FFKM) seals have been developed to meet such unique requirements while providing excellent sealing qualities to comply with modern pharmaceutical processes.

These products are available from the UK authorized distributor Dichtomatik Ltd, and reduce extractables to trace levels while providing excellent steam cycling resistance up to 260°C.

Where in-situ tests have been conducted with saturated steam at 4 bar pressure and 140°C temperature, the Kalrez® 6230 seal parts performed well over a 4 month test duration of 8 hours per day and 5 days per week.

At the end of the test period, the seals exhibited little or no cracks and only minor compression set when compared to competitive perfluoroelastomer (FFKM and FKM) materials.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,100+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Targeting Cannabinoid CB2 Receptors in the CNS
With endogenous cannabinoids considered as a potential target to combat CNS diseases, this article examines the role of CB2R could play in fighting some disorders.
Bacterial Genes Boost Current in Human Cells
Borrowing and tweaking bacterial genes to enhance electrical activity might treat heart, nervous system injury.
Less Frequent Cervical Cancer Screening
HPV-vaccinated women may only need one screening every 5 to 10 years with screening starting later in life.
Cocoa Compound Linked to Some Cardiovascular Biomarker Improvements
The study highlights the urgent need for large, long-term RCTs that improve understanding of how the short-term benefits of cocoa flavanol intake on cardiometabolic biomarkers may be translated into clinical outcomes.
Untangling a Cause of Memory Loss in Neurodegenerative Diseases
The mouse study identifies a possible therapeutic target for a family of disorders.
New Pathway for COPD Biomarker Development
A study from Philip Morris International has highlighted multi-lipid profiling as a potential new pathway for COPD biomarker development.
Stiffening a Blow to Cancer Cells
Researchers develop a way to predict how a tumor tissue's physical properties affect its response to chemotherapy drugs.
Anti-Cancer Drug Uses Tumour mRNA to Identify Responders
Phase I study of novel anti-cancer drug uses tumour mRNA expression to identify patients who will respond to the drug.
New Strategy for Choosing Cancer Drugs
Device can predict tumor responses by measuring cell growth after drug exposure.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos